[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,890,680
  • Shares Outstanding, K 29,688
  • Annual Sales, $ 427,540 K
  • Annual Income, $ -21,020 K
  • EBIT $ -66 M
  • EBITDA $ -41 M
  • 60-Month Beta 1.90
  • Price/Sales 4.30
  • Price/Cash Flow 27.00
  • Price/Book 7.22

Options Overview Details

View History
  • Implied Volatility 103.50% (-4.10%)
  • Historical Volatility 75.66%
  • IV Percentile 79%
  • IV Rank 62.19%
  • IV High 133.95% on 10/23/25
  • IV Low 53.41% on 08/28/25
  • Expected Move (DTE 7) 5.25 (7.62%)
  • Put/Call Vol Ratio 0.66
  • Today's Volume 832
  • Volume Avg (30-Day) 1,014
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 14,969
  • Open Int (30-Day) 17,672
  • Expected Range 63.71 to 74.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.19
  • Number of Estimates 1
  • High Estimate $-0.19
  • Low Estimate $-0.19
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -138.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
58.14 +18.61%
on 07/21/26
72.95 -5.47%
on 07/02/26
+0.31 (+0.45%)
since 06/30/26
3-Month
32.21 +114.10%
on 05/06/26
72.95 -5.47%
on 07/02/26
+6.07 (+9.65%)
since 04/30/26
52-Week
32.21 +114.10%
on 05/06/26
170.87 -59.64%
on 12/02/25
-34.55 (-33.38%)
since 07/30/25

Most Recent Stories

More News
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 3, 2026 in GeneDx Holdings Corp. Lawsuit - WGS

Key Dates and Disclosure Events GeneDx Shareholders Need to Know: From $51 Million Acquisition Promise to $31.2 Million Write-Off in Just 12 Months

WGS : 68.96 (+8.28%)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 29, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

WGS : 68.96 (+8.28%)
WGS DEADLINE ALERT: GeneDx Holdings Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- August 3, 2026 Deadline

SAN FRANCISCO , July 29, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has...

WGS : 68.96 (+8.28%)
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

SAN FRANCISCO , July 29, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed,...

WGS : 68.96 (+8.28%)
Levi & Korsinsky Reminds GeneDx Holdings Corp. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 3, 2026 - WGS

Time-Sensitive: Allegations Focus on Deteriorating Reimbursement Rates and Margin Compression Concealed From GeneDx Investors

WGS : 68.96 (+8.28%)
HAGENS BERMAN, SOBOL SHAPIRO LLP ALERT: GeneDx Holdings Corp. (NASDAQ: WGS) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed, August 3, 2026 Lead Plaintiff Deadline

SAN FRANCISCO , July 28, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in GeneDx Holdings Corp. (NASDAQ: WGS) that a securities fraud class action lawsuit has been filed,...

WGS : 68.96 (+8.28%)
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm

NEW YORK , July 28, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GeneDx Holdings Corp. (NASDAQ: WGS).

WGS : 68.96 (+8.28%)
WGS Deadline: WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit

NEW YORK , July 28, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May...

WGS : 68.96 (+8.28%)
GeneDx Holdings Corp. (NASDAQ: WGS) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action

Lead Plaintiff Deadline: August 3, 2026

WGS : 68.96 (+8.28%)
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 27, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors...

WGS : 68.96 (+8.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 75.91
2nd Resistance Point 72.53
1st Resistance Point 70.74
Last Price 68.96
1st Support Level 65.58
2nd Support Level 62.20
3rd Support Level 60.41

See More

52-Week High 170.87
Fibonacci 61.8% 117.90
Fibonacci 50% 101.54
Fibonacci 38.2% 85.18
Last Price 68.96
52-Week Low 32.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.